Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients with coronavirus, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation. The research is led by infectious disease clinician George Sakoulas, M.D. of Sharp Memorial Hospital and the Sharp Rees-Stealy Medical Group in San Diego, CA, and Associate Professor in the Department of Pediatrics of the University of California San Diego Scho...